Sourcebio International PLC
LSE:SBI
Sourcebio International PLC
LSE:SBI
Price:
115 GBX
4.55%
Market Closed
Updated:
May 14, 2024
EV/GP
Enterprise Value to Gross Profit
Enterprise Value to Gross Profit
2.3
Current
2.3
Median
5.3
Industry
Higher
than median
Lower
than industry value
All Countries
| Market Cap | EV/GP | ||||
|---|---|---|---|---|---|
| UK |
|
Sourcebio International PLC
LSE:SBI
|
85.3m GBP | 2.3 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
92.4B EUR | 4.8 | |
| US |
|
Cigna Corp
NYSE:CI
|
99.1B USD | 4.8 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
70.7B USD | 2.2 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
17.8B USD | 6.1 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
16.1B EUR | 5.4 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
15.6B USD | 6.2 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.9B EUR | 4.3 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
11.8B EUR | 4.3 | |
| US |
|
DaVita Inc
NYSE:DVA
|
12B USD | 5.2 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 128.5 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/GP
N/A
2-Years Forward
EV/GP
N/A
3-Years Forward
EV/GP
N/A
You don't have any saved screeners yet
